Zepp Health Corp
No enriched coverage for $ZEPP in the last 7 days.
No SEC Form 4 filings for $ZEPP in the last 30 days.
See all $ZEPP insider activity →Zepp Health Corporation (NYSE: ZEPP) said it will release its unaudited first-quarter 2026 financial results on June 8, 2026. The company will host a conference call at 9:30 p.m. ET the same day, with a live webcast and an archived version on its investor site. A telephone replay will be available until June 15, 2026.
Zepp Health (ZEPP) reported a Q4 2025 EPS loss of US$0.69 on US$85.2 million in revenue, a significant improvement from the US$2.29 loss in Q4 2024. Despite narrowing quarterly losses and increased revenue, the company remains unprofitable with a trailing twelve-month net loss of US$40.1 million and an annualized earnings decline of 53.8% over five years. The article discusses both bullish arguments, focused on product innovation and premium segment expansion, and bearish concerns about persistent unprofitability and a P/S ratio of 0.9x compared to the industry average of 2.4x.
The maker of low-end wearable devices reported its revenue rose 78.5% in the third quarter, but forecast the rate would ease to about 40% in the current quarter Zepp Health reported a second consecutive quarter of strong revenue growth in the three months to September, as it achieved breakeven on ...
Recent ZEPP coverage spans financial news and earnings.
This is an earnings-timing update that can drive pre-earnings positioning and volatility ahead of reported Q1 2026 results.
Zepp Health has narrowed its Q4 2025 EPS loss significantly compared to the previous year, indicating operational improvement. However, persistent unprofitability and a low P/S ratio suggest ongoing valuation concerns. The positive revenue trend may support short-term price stability, but fundamental challenges remain.
Zepp Health has demonstrated strong revenue growth in Q3, with a 78.5% increase, indicating operational momentum. However, the forecasted slowdown to approximately 40% growth in the current quarter suggests potential deceleration.
ZEPP demonstrates a strong bullish sentiment aligned with the positive news about Zepp Health's recovery and growth potential.
Zepp Health (NYSE:ZEPP) shows signs of overbought conditions with RSI indicating possible correction. Technical analysis suggests a short-term downtrend, aligning with the article's warning.
alphai scores every news story that mentions ZEPP with an AI model for sentiment and relevance, and aggregates insider trades from Zepp Health Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Zepp Health Corporation (NYSE: ZEPP) said it will release its unaudited first-quarter 2026 financial results on June 8, 2026. The company will host a conference call at 9:30 p.m. ET the same day, with a live webcast and an archived version on its investor site. A telephone replay will be available until June 15, 2026.
1 min readZepp Health (ZEPP) reported a Q4 2025 EPS loss of US$0.69 on US$85.2 million in revenue, a significant improvement from the US$2.29 loss in Q4 2024. Despite narrowing quarterly losses and increased revenue, the company remains unprofitable with a trailing twelve-month net loss of US$40.1 million and an annualized earnings decline of 53.8% over five years. The article discusses both bullish arguments, focused on product innovation and premium segment expansion, and bearish concerns about persistent unprofitability and a P/S ratio of 0.9x compared to the industry average of 2.4x.
3 min readThe maker of low-end wearable devices reported its revenue rose 78.5% in the third quarter, but forecast the rate would ease to about 40% in the current quarter Zepp Health reported a second consecutive quarter of strong revenue growth in the three months to September, as it achieved breakeven on ...
3 min readThe Amazfit brand has helped Zepp Health bounce back in a big way after years of negative returns.
3 min readAs of July 9, 2025, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days ...
3 min readImage source: The Motley Fool.Monday, May 19, 2025 at 7 p.m. ETChairman of the Board of Directors and Chief Executive Officer - Wang Huang WangContinue reading ...
7 min read
